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Most cases of thrombotic thrombocytopenic purpura (TTP) are considered idiopathic without an identifiable etiologic agent. It has been previously reported that a number of patients with TTP had a urinary tract infection (UTI)
Idiopathic thrombotic thrombocytopenic purpura (TTP), a thrombotic microangiopathic anemia, has no known stimulus. The disease, commonly seen in previously healthy people, is characterized by microangiopathic hemolytic anemia and thrombocytopenia without any other likely causes. 1,2 Most patients with idiopathic TTP have a deficiency in activity of ADAMTS13, a von Willebrand factor (vWF)-cleaving protease, and demonstrate an associated autoantibody. 3, 4 Before the routine use of therapeutic plasma exchange (TPE) to treat patients with TTP, the mortality was approximately 90%. 2 There have been multiple reports of TTP associated with known or occult bacterial infections. [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] In our center, we noted a possible association of urinary tract infections (UTIs) with TTP. 5 This raises the possibility of molecular mimicry between antibodies directed against the infectious etiologic agent and the antibodies targeting ADAMTS13. To further support our conjecture that antibodies targeting pathogens may precipitate the onset of TTP, we conducted a retrospective study of the incidence of UTI in patients with idiopathic TTP.
Materials and Methods
All patients at University of North Carolina Hospitals who underwent TPE for TTP from 1999 through 2007 were retrospectively identified. Patient hospital records were examined for other likely causes of a thrombotic microangiopathic anemia. Only patients with idiopathic TTP were included in the study. Exclusion criteria are listed in ❚Table 1❚.
Hospital records of patients admitted for idiopathic TTP were then reexamined for evidence of a UTI. Patients with a UTI were divided into 4 groups ❚Table 2❚ based on the clinical history and laboratory findings. This study was approved by the University of North Carolina at Chapel Hill Biomedical Institutional Review Board.
Definition of Terms
A patient visit consists of all admissions for TTP for a specific patient within a 1-month period. Documented laboratory evidence of a UTI is defined as a positive urine culture. Weak laboratory evidence of a UTI is defined as a urinalysis positive for leukocyte esterase and nitrate and/or the appearance of WBCs together with clinical findings of a UTI and a negative urine culture.
Results
Within the 8-year study period, we identified 99 patients with TTP who were associated with a total of 129 patient visits. We excluded 39 patient visits for secondary causes of thrombotic microangiopathy. Of the 90 remaining visits, 76 involved female patients and 14 involved male patients. Of the patient visits, 73 (81%) had an associated urinalysis and/ or urine culture. Of the 90 TTP visits, 21 (23%) UTIs were identified ❚Figure 1❚, with the majority occurring in groups 1 and 2. Of the 21 UTIs, 20 occurred in female patient visits and 1 occurred in a male patient visit. A variety of organisms were identified as potential etiologic agents in these infections ❚Table 3❚. The organism identification was not always readily available from other institutions for group 2 patients.
Of the 90 visits, 23 had a pre-TPE ADAMTS13 performed. In 18, there was a severe deficiency of ADAMTS13 (<5%), 3 had moderate levels (5%-67%), and 2 had normal levels (>67%). Of the 21 with low ADAMTS13 activity, inhibitors ranged from 0 to more than 8 inhibitor units, with a mean of 2.1 and a median of 1.5 inhibitor units.
Discussion
This retrospective study identified a significant incidence of UTI in TTP patient visits. Of 90 TTP patient visits, 23% involved a UTI just before or after hospital admission. A systematic review of the scientific literature searching ❚Figure 1❚ Thrombotic thrombocytopenic purpura (TTP) patient visits associated with urinary tract infections (UTI). Group 1, laboratory evidence of UTI on admission; group 2, UTI just before admission; group 3, UTI that developed during hospitalization; and group 4, weak laboratory evidence of UTI.
for idiopathic TTP and infection identified numerous case reports implicating an association between infections and TTP. [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] This report represents the first study designed to compare the incidence of a specific type of infection in patients with TTP. The incidence of UTI in TTP patient visits may be attributed to a number of causes. The incidence supports the possibility of molecular mimicry between an antibody directed against the etiologic agent causing the UTI and the ADAMTS13 protease. Another possibility is that the infection causes endothelial changes or damage that contributes to the formation of microthrombi. Patients with severe infections have higher levels of vWF antigen compared with healthy control subjects and patients without sepsis. 25 In addition, inflammatory cytokines such as interleukin-8 and tumor necrosis factor α stimulate the release of ultralarge vWF, and interleukin-6 inhibits the cleavage of ultralarge vWF by ADAMTS13 in flowing, as opposed to static, conditions. 26 These factors could contribute to the disruption of the normal amounts and the processing of ultralarge vWF.
The strengths of this study include the relatively large number of patients with TTP from a single institution forming the case group and the inclusion of only idiopathic TTP cases, eliminating all cases involving secondary causes of TTP. The study is limited by our difficulty in identifying and comparing with an ideal control group. Not all patients had a urinalysis or urine culture at the time of their hospitalization, which is an inevitable weakness of a retrospective study. The assumption was made that the patients for whom no urinalysis or urine culture was done were asymptomatic and the clinical suspicion for UTI was low.
Conclusions
Our study demonstrates a high incidence of UTI in TTP patient visits at our university medical center. Future prospective studies looking at this association will help to elucidate the true incidence of UTI and association of infection with TTP in this patient population. This study raises the question of molecular mimicry between antibodies directed against infectious agents and the ADAMTS13 protease and the possibility of applying molecular techniques to identify genetic similarities between the protease and bacterial proteins. These findings suggest the need to diligently identify and treat bacterial infections, which may serve as an antigenic stimulus in patients with TTP.
